Skip to main content

Advertisement

SpringerLink
Log in

Propagation of cytotoxic effectors from chronic myeloid leukemia patients and cloning of cytotoxic T cells

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Cytotoxic cells (CTCs) generated from peripheral blood lymphocytes of 5 chronic myeloid leukemia (CML) patients in remission on stimulation with autologous leukemic cells and allogeneic lymphocytes (3-cell assay), were propagated in vitro in interleukin-2 (IL-2)-containing medium and periodic stimulation with autologous leukemic cells, for a period of 4 to 6 months. During this period, the cells were assessed for phenotype and for cytotoxic responses in a 4-h 51Cr release microcytotoxicity assay. The CTCs continued to show specific lysis of autologous leukemic cells and bone marrow (BM) cells. However, the nonspecific lysis of natural killer (NK) targets and the proportion of cells showing NK phenotype (HNK-1 antigen) increased progressively on cultivation in IL-2-containing medium. Therefore cells showing CD8 phenotype and specific cytotoxic function were segregated by cloning CTCs under the condition of limiting dilution in the presence of allogeneic feeder cells and IL-2-containing medium. Three cytotoxic T cell (CTL) clones expressing CD3+, CD8+, and HLA DR+ phenotypes were obtained from CTCs of 2 CML patients. These clonoid populations, maintained in IL-2-containing medium and periodic antigenic stimulation with autologous leukemic cells, showed specific lysis of autologous leukemic cells and BM cells even at lower (10:1) effector:target ratios. They did not kill K562 (erythroblastoid leukemic NK target cell line) cells and autologous phytohemagglutinin-induced blasts. These clones apparently functioned in an MHC-restricted manner as they did not lyse allogeneic CML cells which would also express a similar set of maturation antigens if sensitization was, as it appeared, against these antigens. Finally, interaction of autologous BM cells with CTL clones reduced the colony forming potential of BM cells only to the extent of 18%–30%. The results therefore indicate that such CTL clones can possibly be used in adoptive immunotherapy as they showed minimal BM toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abo T, Balch CM (1981) A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol 127:1024

    Google Scholar 

  2. Abo T, Miller CA, Balch CM (1984) Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu 7) and Leu 11 antigens in the blood and lymphoid tissues from fetuses, neonates and adults. Eur J Immunol 14:616

    Google Scholar 

  3. Alvarez JM, DeLandazuri MO, Bonnard GD, Herberman RB (1978) Cytotoxic activities of normal cultured human T cells. J Immunol 121:1270

    Google Scholar 

  4. Anichini A, Fossati G, Parmiani G (1985) Clonal analysis of cytotoxic T lymphocyte response to autologous human metastatic melanoma. Int J Cancer 35:683

    Google Scholar 

  5. Bast RC (1985) Principles of cancer biology: tumor immunology. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer principles and practice of oncology, vol 1. Lippincott Company, Philadelphia, p 125

    Google Scholar 

  6. DeVries JE, Spits H (1984) Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. J Immunol 132:510

    Google Scholar 

  7. Ettinghausen SE, Rosenberg SA (1986) Adoptive immunotherapy of cancer using lymphokine-activated killer cells and recombinant interleukin-2. Springer Semin Immunopathol 9:51

    Google Scholar 

  8. Fefer A, Cheever MA, Greenberg PD (1982) Lymphocyte transfer as potential cancer immunotherapy. In: Mihic E (ed) Immunological approaches to cancer therapeutics. John Wiley & Sons, New York, p 333

    Google Scholar 

  9. Ferrini S, Biassoni R, Morretta A, Bruzzone M, Nicolin A, Morretta L (1985) Clonal analysis of T lymphocytes isolated from ovarian carcinoma ascitic fluid: Phenotypic and functional characterization of T cell clones capable of lysing autologous carcinoma cells. Int J Cancer 36:337

    Google Scholar 

  10. Gillis S, Smith KA (1977) Long-term culture of tumor specific cytotoxic T cells. Nature 268:154

    Google Scholar 

  11. Gillis S, Ferm ME, Ou W, Smith KA (1978) T cell growth factor, parameters of production and quantitative microassay for activity. J Immunol 120:2027

    Google Scholar 

  12. Grimm EA, Rosenberg SA (1984) The human lymphokine activated killer cell phenomenon. In: Pick E (ed) Lymphokines, vol 9. Academic Press, New York, p 279

    Google Scholar 

  13. Herberman RB (1983) Lymphoid cells in immune surveillance against malignant transformation. In: Gallin JI, Fauci AS (eds) Advances in host defense mechanisms, vol 2. Raven Press, New York, p 241

    Google Scholar 

  14. Herin M, Lemoine C, Weynants P, Vessiere F, VanPel A, Knuth A, Devos R, Boon T (1987) Production of stable cytotoxic T-cell clones directed against autologous human myeloma. Int J Cancer 39:390

    Google Scholar 

  15. Ichino Y, Ishikawa T (1983) Cytolysis of autologous fresh osteosarcoma cells by human cytotoxic T lymphocytes propagated with T cell growth factor. Gann 74:584

    Google Scholar 

  16. Ichino Y, Ishikawa T (1984) Generation of human cytotoxic T lymphocytes against fresh autologous and allogeneic solid tumors by mixed lymphocyte tumor cell culture with T cell growth factor. Gann 75:436

    Google Scholar 

  17. Khare AG, Advani SH, Gangal SG (1981) In vitro generation of lymphocytotoxicity to autochthonous leukemic cells in chronic myeloid leukemia. Br J Cancer 43:13

    Google Scholar 

  18. Morgan DA, Russetti FW, Gallo RC (1976) Selective in vitro growth of T lymphocytes from normal human bone marrow. Science 193:1007

    Google Scholar 

  19. Mukherji B, MacAlister TJ (1983) Clonal analysis of cytotoxic T cell response against human melanoma. J Exp Med 158:240

    Google Scholar 

  20. Ortaldo JR, Timonen T, Bonnard GD (1980) Natural killing and antibody dependent cell mediated cytotoxicity by human cultured T cells. Behring Inst Mitt 67:258

    Google Scholar 

  21. Rabinowich H, Cohen R, Bruderman I, Steiner Z, Klajman A (1987) Functional analysis of mononuclear cells by infiltrating tumors: Lysis of autologous human tumor cells by culture infiltrating lymphocytes. Cancer Res 47:173

    Google Scholar 

  22. Rosenberg SA, Eberlein TJ, Grimm EA, Lotze MJ, Mazumder A, Rosenstein M (1982) Development of long-term cell lines and lymphoid clones reactive against murine and human tumors: A new approach to the adoptive immunotherapy of cancer. Surgery 92:328

    Google Scholar 

  23. Sarin PS, Gallo RC (1984) Human T cell growth factor (TCGF). CRC Crit Rev Immunol 4:279

    Google Scholar 

  24. Slankard-Chahinian M, Holland JF, Gordan RE, Becker J, Ohnuma T (1984) Adoptive autoimmunotherapy: Cytotoxic effect of an autologous long-term cell line on malignant melanoma. Cancer 53:1066

    Google Scholar 

  25. Spitz H, Yssel H, Leewenberg J, DeVries JE (1985) Antigen specific cytotoxic T cell and antigen specific proliferating T cell clones can be induced to cytotoxic activity by monoclonal antibodies against T3. Eur J Immunol 15:88

    Google Scholar 

  26. Somasundaram R, Rao SGA, Advani SH, Gangal SG (1988) In vitro generation of effector cells cytotoxic to autologous targets from chronic myeloid leukemia patients in remission. Cancer Immunol Immunother (in press)

  27. Vose BM, Bonnard GD (1982) Human tumor antigens defined by cytotoxicity and proliferative response of cultured lymphoid cells. Nature 296:359

    Google Scholar 

  28. Vose BM, White W (1983) Tumor reactive lymphocytes stimulated in mixed lymphocyte and tumor culture. Clonal analysis of effector cells in cytotoxic and proliferative assays. Cancer Immunol Immunother 15:227

    Google Scholar 

  29. Weiss A, Imboden JB (1987) Cell surface molecules and early events involved in human T lymphocyte activation. In: Dixon FJ (ed) Advances in immunology, vol 41. Academic Press, New York, pp 1

    Google Scholar 

  30. Zarling JM, Bach FH (1979) Continuous culture of T cells cytotoxic for autologous human leukemic cells. Nature 280:685

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Immunology Division, Cancer Research Institute, Tata Memorial Centre, Parel, 400 012, Bombay, India

    R. Somasundaram & Sudha G. Gangal (Head)

  2. Tata Memorial Hospital, Tata Memorial Centre, Parel, 400 012, Bombay, India

    Suresh H. Advani

Authors
  1. R. Somasundaram
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suresh H. Advani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sudha G. Gangal
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Somasundaram, R., Advani, S.H. & Gangal, S.G. Propagation of cytotoxic effectors from chronic myeloid leukemia patients and cloning of cytotoxic T cells. Cancer Immunol Immunother 27, 183–189 (1988). https://doi.org/10.1007/BF00200025

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00200025

Keywords

Search

Navigation